C. Martin

发表

Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5

N. Khan, P. Seeberger, M. Witzenrath, 2017, Proceedings of the National Academy of Sciences.

Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans

P. Seeberger, L. Hartmann, Felix Wojcik, 2016, Nature Communications.

Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections

C. Daniel, J. Mattner, A. Ensser, 2019, ACS chemical biology.

A Self-Assembling Peptide Scaffold for the Multivalent Presentation of Antigens.

Hans v Berlepsch, E. Zacco, P. Seeberger, 2015, Biomacromolecules.

Diversity-oriented synthesis of inner core oligosaccharides of the lipopolysaccharide of pathogenic Gram-negative bacteria.

P. Seeberger, C. Martin, S. Oishi, 2013, Journal of the American Chemical Society.

Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine.

M. Oberli, P. Seeberger, F. Broecker, 2013, Chemical communications.

Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope.

M. Oberli, J. Mattner, P. Seeberger, 2013, Journal of the American Chemical Society.

Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of Leishmania.

M. Antoniou, C. Bogdan, P. Seeberger, 2013, ACS chemical biology.

Total synthesis of the core tetrasaccharide of Neisseria meningitidis lipopolysaccharide, a potential vaccine candidate for meningococcal diseases

P. Seeberger, C. Martin, You Yang, 2012 .

2‐Methoxyimino Acetic Acid

D. Ma, C. Martin, 2016 .

Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit.

P. Seeberger, M. Weishaupt, C. Martin, 2011, Chemical communications.

Microbe-focused glycan array screening platform

M. Wimmerová, P. Seeberger, F. Fieschi, 2019, Proceedings of the National Academy of Sciences.

Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites

D. Suckau, P. Seeberger, Eike-Christian Wamhoff, 2016, Scientific Reports.

Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections.

J. Mattner, P. Seeberger, F. Broecker, 2016, Cell chemical biology.